AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Abivog GM 1mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alpic Biotech Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Abivog GM 1mg/500mg/0.2mg Tablet SR

Diabeva Trio 1mg/500mg/0.2mg Extended-Release Tablets are classified as anti-diabetic medications. This combination therapy treats type 2 diabetes in adults by helping regulate blood glucose. Diabeva Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function) are recommended.

Uses of Abivog GM 1mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Abivog GM 1mg/500mg/0.2mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Abivog GM 1mg/500mg/0.2mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.

Common Side effects of Abivog GM 1mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Abivog GM 1mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Abivog GM 1mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.

How Abivog GM 1mg/500mg/0.2mg Tablet SR works:

Abivog GM extended-release tablets (1 mg/500 mg/0.2 mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Abivog GM 1mg/500mg/0.2mg Tablet SR with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Abivog GM 1mg/500mg/0.2mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Abivog GM 1mg/500mg/0.2mg SR tablets are likely incompatible. Preliminary human studies indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Abivog GM 1mg/500mg/0.2mg Tablet SR carries a high risk for individuals with kidney impairment and is best avoided. Patients with severe kidney disease should definitely not use this medication. Medical advice is essential.

LiverLiverCAUTION

Patients with liver impairment should use Abivog GM 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a reduced Abivog GM 1mg/500mg/0.2mg Tablet SR dose; however, its use is contraindicated in those with severe liver dysfunction. Medical advice is recommended.

What if you forget to take Abivog GM 1mg/500mg/0.2mg Tablet SR :

Should you forget to take your Abivog GM 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Abivog GM 1mg/500mg/0.2mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Abivog GM 1mg/500mg/0.2mg Tablet SR

Abivog GM 1mg/500mg/0.2mg Extended-Release Tablet contains glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults, augmenting the effects of diet and exercise on blood sugar control. Glimepiride stimulates pancreatic insulin secretion to reduce blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal glucose elevations. This medication is unsuitable for type 1 diabetes mellitus.
Patients taking Abivog GM 1mg/500mg/0.2mg Tablet SR may experience common adverse reactions including low blood glucose, nausea, diarrhea, taste disturbances, flatulence, abdominal pain, headache, skin eruptions, and respiratory infections.
Patients with hypersensitivity to Abivog GM 1mg/500mg/0.2mg Tablet SR constituents or inactive ingredients should not take this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, and those with inflammatory bowel conditions, colonic ulcers, or underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Abivog GM 1mg/500mg/0.2mg Tablet SR with alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and raises the probability of lactic acidosis.
Indeed, Abivog GM 1mg/500mg/0.2mg SR tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Having readily available glucose tablets, honey, or fruit juice is recommended.
Retain this medication in its original, tightly sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Abivog GM 1mg/500mg/0.2mg...
78
MRP 95
17% off